In Depth 7 Jun 2023
How Ireland connects AI and life sciences
Depending on your point of view, artificial intelligence (AI) can create jobs, make life easier, and solve many global problems;…
Ireland
- Latest Posts
News and Trends 25 Apr 2023
Gene therapy and chemotherapy could be new osteosarcoma treatment option
New research has identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma, a bone cancer…
News and Trends 17 Apr 2023
Aer Therapeutics raises $36M to tackle lung diseases
Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) biopharmaceutical spin-out company developing novel…
Best in Biotech 17 Mar 2023
Greener Pastures for Biotech? 7 Great Biotechs from Ireland
Shamrocks, leprechauns, rolling green fields and Guinness beer all quickly bring Ireland to mind. Beyond these postcard-ready images, Ireland has an…
ADVERTISEMENT
News and Trends 11 Jan 2023
Renexxion goes to FDA with cystic fibrosis drug
Renexxion Ireland Limited has opened an investigational new drug (IND) application with the U.S Food and Drug Administration (FDA) for…
News and Trends 6 Dec 2022
INSPIRE launched to develop inhaled gene therapy for the treatment of lung cancer
OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project funded by Horizon Europe. In…
News and Trends 6 Dec 2022
New brain tumor subtypes discovery may help develop treatments for incurable brain cancer
Research led by RCSI University of Medicine and Health Sciences in Ireland has discovered three new subtypes of brain tumor.…
News and Trends 21 Nov 2022
Genomic Data Infrastructure Ireland project to support discovery of genetic causes of disease
RCSI University of Medicine and Health Sciences and FutureNeuro are co-leading, with University College Dublin, the Irish element of a…
News and Trends 16 Nov 2022
Poolbeg-led consortium awarded €2.3m to develop oral vaccine platform
EncOVac, a consortium led by Poolbeg Pharma, has been awarded €2.3m ($2.4 million) in non-dilutive grant funding to progress its…
News and Trends 14 Nov 2022
Priothera’s Mocravimod improves survival for patients with hematological malignancies
Priothera, a biotechnology company developing its S1P receptor modulator compound Mocravimod, has announced that positive data from a clinical trial…
ADVERTISEMENT
News and Trends 13 Oct 2022
Xcell Biosciences and aCGT Vector pushing ahead with cell and gene therapies
Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and aCGT Vector, a point-of-care cell…
News and Trends 21 Sep 2022
Poolbeg to investigate melioidosis vaccine candidate
Poolbeg Pharma has signed an exclusive agreement with University College Dublin (UCD) through NovaUCD, the university’s knowledge transfer office, for…
News and Trends 31 Aug 2022
Emactuzumab designated as an orphan medicinal product for TGCT in Europe
SynOx Therapeutics Limited says its novel monoclonal antibody, emactuzumab, in development for the treatment of tenosynovial giant cell tumor (TGCT)…
News and Trends 24 Aug 2022
Gene therapies for lung cancer identified by international team of scientists
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international team of scientists have discovered.…
News and Trends 28 Jun 2022
Trinity, St. James’s and Legend Biotech collaborating on solid tumors
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic collaboration with Legend Biotech, a…
News and Trends 21 Apr 2021
Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded as Vascepa in the US…
ADVERTISEMENT
News and Trends 12 Dec 2019
Iterum Therapeutics Reels from Antibiotic Phase III Fail
An antibiotic candidate developed by the Irish company Iterum Therapeutics has failed to meet the main goal of a phase…
News and Trends 26 Sep 2019
Positive Phase III Results for Narcolepsy Drug with Low Cardiovascular Risk
The narcolepsy drug, developed by Irish company Jazz Pharmaceuticals, has a lower salt content than the current treatment Xyrem, making…
More News! 23 May 2019
Irish Life Sciences VC Raises €118M Fund with European Focus
Fountain Healthcare Partners has raised €118M in its third fund dedicated to investing in life sciences, with the majority of…
News and Trends 13 Feb 2019
First Plant in the Works to Turn Dairy Byproducts Into Plastics
The company Glanbia Ireland is planning to construct the first industrial biorefinery that transforms dairy waste products into lactic acid,…
